 The Executive Board of Biofrontera AG NASDAQ ticker symbol: BFRA, ISIN: DE0006046113, today resolved, with the approval of the Supervisory Board, to issue two qualified subordinated mandatory convertible bonds. The following are to be issued i 0.5 qualified subordinated mandatory convertible bond 20202024 and ii 1.0 qualified subordinated mandatory convertible bond 20202026. Both mandatory convertible bonds consist of up to 1,600,000 bonds with a principal amount of EUR 5.00 each and a total principal amount of up to EUR 8,000,000. 